What’s Going On With Nvidia Stock Friday?

Nvidia Corp (NASDAQ: NVDA) stock is trading lower Friday in line with the broader index after July PPI data showed 

Nvidia Corp (NASDAQ:NVDA) stock is trading lower Friday in line with the broader index after July PPI data showed greater-than-expected inflation.

Shares of semiconductor and chip stocks are trading lower amid overall market weakness.

The stock also remains vulnerable to concerns fuelled by U.S.’s additional sanctions on China concerning artificial intelligence chips. The country accounts for a sizable revenue due to the ChatGPT frenzy.

Chinese companies harboring AI ambitions, including Alibaba Group Holding (NYSE:BABA), have ordered Nvidia AI chips in bulk, fearing a supply crisis due to U.S.’s additional embargo on the industry.

Separately, concerns loom over Nvidia’s ability to supply AI chips, as the demand will likely outdo the supply. The crisis will probably be a tailwind for Advanced Micro Devices, Inc (NASDAQ:AMD) and Samsung Electronics Co, Ltd (OTC:SSNLF).

Broader index ETF Invesco QQQ Trust, Series 1 (NASDAQ:QQQ) traded lower by close to 1%. SPDR S&P 500 (NYSE: SPY) is also down.

BofA Securities analyst Vivek Arya expects the sentiment to be more measured after last quarter’s upbeat report.

Upside supply driven, especially as data-center mix-shift shifts to H100 ($30K vs. A100 at $10K), downside risk could be gaming which is vulnerable to weak macro trends. 

Post-earnings reaction could see near-term stock consolidation following the 200%+ move up YTD (vs. SOX up 46%).

Price Action: NVDA shares traded lower by 3.10% at $410.72 on the last check Friday.

Photo by Mizter_X94 via Pixabay

Total
0
Shares
Related Posts
Read More

CBD Giant’s Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoY

cbdMD reported a 27% year-over-year drop in net sales for the fourth quarter of 2023, totaling $5.7 million. The company attributed the decline to industry trends, reduced marketing spend, and lower wholesale pricing for its new high-strength products. For the full fiscal year 2023, net sales reached $24.2 million, down from $35.4 million in the previous year. Gross profit for the year was approximately $15 million, a decrease from $22.3 million in fiscal 2022. The company reported a net loss of about $23 million, compared to $70 million in 2022. Operating expenses fell to $24.2 million from $40 million in the prior year. cbdMD's working capital on September 30, 2023, was $3.4 million, down from $10.7 million on the same date in 2022. The company also launched its hempMD and ATRx brands in 2023, expanding its product channels into Amazon and other consumer products channels.

YCBD